AMCP webinar that detailed the state of the performance measurement landscape, profiles how quality impacts team-based models of care, the Enhanced MTM program, and others, and describes why this impact matters in managed care.
AMCP webinar that reviewed the FDA Reauthorization Act of 2017 (FDARA) which authorizes user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilars.